PTC Therapeutics
PTCT
#2794
Rank
NZ$10.07 B
Marketcap
NZ$125.46
Share price
-1.18%
Change (1 day)
39.72%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: NZ$10.07 Billion

As of February 2026 PTC Therapeutics has a market cap of NZ$10.07 Billion. This makes PTC Therapeutics the world's 2794th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$10.07 B-7.51%
2025NZ$10.89 B76.08%
2024NZ$6.18 B88.08%
2023NZ$3.28 B-25.04%
2022NZ$4.38 B6.42%
2021NZ$4.12 B-28.57%
2020NZ$5.77 B30.67%
2019NZ$4.41 B70.59%
2018NZ$2.58 B165.72%
2017NZ$0.97 B80.28%
2016NZ$0.54 B-66.34%
2015NZ$1.60 B-26.14%
2014NZ$2.17 B342.21%
2013NZ$0.49 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of PTC Therapeutics was reported to be:

NZ$10.07 Billion
by Nasdaq info icon info icon
NZ$10.07 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$473.86 B 4,604.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$200.11 B 1,886.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.43 B-85.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.54 B-64.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.22 B-97.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$18.16 B 80.31%๐Ÿ‡บ๐Ÿ‡ธ USA